[dabigv13]

Here's a Scientific American article from May that provides some encouraging information about the response of T-cells to vaccines designed to target the spike protein:

https://www.scientificamerican.com/artic...a-vaccine/

Note that while the vaccines that take a targeted approach do target the spike protein, none of the research that guy did was on vaccines. We don't know if vaccines that are using the spike protein itself, or nucleic acid that produces the spike protein, will produce the same T-cell response as that to spike protein after infection. Or if a T-cell response that also targets other epitopes besides the spike protein (which the paper at the start of this thread looked at as well) would be more durable or protective.

It may be that the first vaccines we get may be decent, but not as good as later ones. Or some types of vaccines may require more than one administration. Still a lot to learn.

[dabigv13]

Here's a Scientific American article from May that provides some encouraging information about the response of T-cells to vaccines designed to target the spike protein:

https://www.scientificamerican.com/artic...a-vaccine/

Note that while the vaccines that take a targeted approach do target the spike protein, none of the research that guy did was on vaccines. We don't know if vaccines that are using the spike protein itself, or nucleic acid that produces the spike protein, will produce the same T-cell response as that to spike protein after infection. Or if a T-cell response that also targets other epitopes besides the spike protein (which the paper at the start of this thread looked at as well) would be more durable or protective.

It may be that the first vaccines we get may be decent, but not as good as later ones. Or some types of vaccines may require more than one administration. Still a lot to learn.